prostate refs

www.andropause.org.uk

Erection Problems – Viagra and other treatments.

Heart, circulation, and the effects of testosterone.

Hormone Replacement Therapy (HRT) for men

Prostate – Screening, benign enlargement and cancer.

Testosterone, the brain and psyche

<%if session("committee") = "YES" then%>

<%end if%>

Reference list - Prostate – Screening, benign enlargement and cancer

1. Auvinen A, Tammela T, Stenman U-H, Uusi-Erkkila I, Leinonen J, Schroder FH et al. Screening for prostate cancer using serum prostate-specific antigen: A randomised, population-based pilot study in Finland. British Journal of Cancer Vol 74.(4.) (pp.568.-572.), 1996.

2. Bangma CH, Blijenberg BG, Schroder FH. Prostate-specific antigen: Its clinical use and application in screening for prostate cancer. Scandinavian Journal of Clinical & Laboratory Investigation - Supplement Vol 55.(221.) (pp.35.-44.), 1995.

3. Bangma CH, Rietbergen JW, Kranse R, Blijenberg BG, Petterson K, Schroder FH et al. The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population. Journal d.Urologie Vol 157.(6.) (pp.2191.-2198.), 1997.

4. Beemsterboer PM, Kranse R, De KH, Habbema JF, Schroder FH. Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam). International Journal of Cancer Vol 84.(4.) (pp.437.-441.), 1999.

5. Carlson GD, Calvanese CB, Partin AW. An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 cases. Urology 1998;52:455-61.

6. Carter HB, Pearson JD, Metter EJ, Chan DW, Andres R, Fozard JL et al. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. Prostate 1995;27:25-31.